https://www.prnewswire.com/news-releases/ioncologi-inc-acquires-targimmune-therapeutics-to-expand-and-strengthen-immunotherapy-pipeline-against-solid-tumors-302402307.html?mkt_tok=NjI3LUNQSy0xNjIAAAGZQ5dYXYMOgWJ3-o3t811AfaVXrEfH4X75ViB4jQ5N3eAsf48Bxam43n9x-_iB8dLGxH1fX9NNNX1Fo77vNfllVhvU3K87a8l6b29N2nsWiudG
iOncologi, Inc. Acquires TargImmune Therapeutics to Expand and Strengthen Immunotherapy Pipeline...
/PRNewswire/ -- iOncologi, Inc., a clinical-stage biopharmaceutical company focused on advancing immunotherapy platform technologies, today announced the...
incacquirestherapeutics
https://www.targimmune.com/
TargImmune
At TargImmune our mission is to significantly improve survival of cancer patients.